Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
7.61
-0.04 (-0.52%)
Oct 22, 2024, 4:00 PM EDT - Market closed

Vir Biotechnology Statistics

Total Valuation

VIR has a market cap or net worth of $1.04 billion. The enterprise value is $3.28 million.

Market Cap 1.04B
Enterprise Value 3.28M

Important Dates

The next confirmed earnings date is Thursday, October 31, 2024, after market close.

Earnings Date Oct 31, 2024
Ex-Dividend Date n/a

Share Statistics

VIR has 136.64 million shares outstanding. The number of shares has increased by 1.32% in one year.

Shares Outstanding 136.64M
Shares Change (YoY) +1.32%
Shares Change (QoQ) +0.70%
Owned by Insiders (%) 5.13%
Owned by Institutions (%) 53.29%
Float 91.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 13.03
Forward PS 14.70
PB Ratio 0.73
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.51, with a Debt / Equity ratio of 0.08.

Current Ratio 12.51
Quick Ratio 12.01
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -29.78% and return on invested capital (ROIC) is -18.56%.

Return on Equity (ROE) -29.78%
Return on Assets (ROA) -16.55%
Return on Capital (ROIC) -18.56%
Revenue Per Employee $134,373
Profits Per Employee -$822,896
Employee Count 587
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax -9.23M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.94% in the last 52 weeks. The beta is 0.46, so VIR's price volatility has been lower than the market average.

Beta (5Y) 0.46
52-Week Price Change -9.94%
50-Day Moving Average 7.90
200-Day Moving Average 9.31
Relative Strength Index (RSI) 47.41
Average Volume (20 Days) 721,631

Short Selling Information

The latest short interest is 5.73 million, so 4.19% of the outstanding shares have been sold short.

Short Interest 5.73M
Short Previous Month 5.97M
Short % of Shares Out 4.19%
Short % of Float 6.26%
Short Ratio (days to cover) 6.93

Income Statement

In the last 12 months, VIR had revenue of $78.88 million and -$483.04 million in losses. Loss per share was -$3.58.

Revenue 78.88M
Gross Profit -369.71M
Operating Income -518.05M
Pretax Income -492.27M
Net Income -483.04M
EBITDA -500.21M
EBIT -518.05M
Loss Per Share -$3.58
Full Income Statement

Balance Sheet

The company has $1.15 billion in cash and $114.51 million in debt, giving a net cash position of $1.04 billion or $7.59 per share.

Cash & Cash Equivalents 1.15B
Total Debt 114.51M
Net Cash 1.04B
Net Cash Per Share $7.59
Equity (Book Value) 1.43B
Book Value Per Share 10.50
Working Capital 1.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$450.99 million and capital expenditures -$7.79 million, giving a free cash flow of -$458.78 million.

Operating Cash Flow -450.99M
Capital Expenditures -7.79M
Free Cash Flow -458.78M
FCF Per Share -$3.36
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -656.79%
Pretax Margin -624.10%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -580.48%

Dividends & Yields

VIR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.32%
Shareholder Yield -1.32%
Earnings Yield -46.45%
FCF Yield -44.12%
Dividend Details

Analyst Forecast

The average price target for VIR is $36.80, which is 383.57% higher than the current price. The consensus rating is "Buy".

Price Target $36.80
Price Target Difference 383.57%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 23.33%
EPS Growth Forecast (5Y) -13.35%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

VIR has an Altman Z-Score of 3.15 and a Piotroski F-Score of 2.

Altman Z-Score 3.15
Piotroski F-Score 2